An Examination of the Joint Contributions of Socioeconomic Disadvantage, Genetics, and COVID-19 on the Development of Delay Discounting and Substance Use Across Adolescence
社会经济劣势、遗传学和 COVID-19 对青春期延迟贴现和药物使用发展的共同贡献的检验
基本信息
- 批准号:10583195
- 负责人:
- 金额:$ 43.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAdolescenceAdolescentAdolescent BehaviorAdultAgeBehaviorCOVID-19COVID-19 pandemicChildChild DevelopmentChildhoodChoice BehaviorChronicClinicalCommunitiesDataDecision MakingDevelopmentDimensionsDisadvantagedEnvironmentEtiologyEventExposure toFrequenciesFutureGeneticGenetic DeterminismGenetic RiskGenetic VariationGenotypeGoalsHealthHeritabilityIndividualInterventionInvestigationJointsLengthLinkLiteratureLongevityLongitudinal StudiesMeasuresMediatingMissionModelingNational Institute of Drug AbuseOutcomePathway interactionsPatternPhenX ToolkitPlayPovertyPreventionPrevention approachProcessPublic HealthResearchResourcesRewardsRiskRisk BehaviorsRisk FactorsRoleSamplingSeveritiesShapesStructureSubstance Use DisorderSumSymptomsSystemTaxesTestingTimeTimeLineTraumaYouthadverse childhood eventsagedalcohol use disordercognitive developmentcost effectivecritical developmental perioddiscountingenvironmental stressorexecutive functionexperienceexternalizing behaviorgenetic risk factorgenetic variantgenome wide association studyhealth goalshealth inequalitiesimprovedinsightlongitudinal datasetmeetingsmodifiable risknovelpolygenic risk scorepreferencereduced substance userepositorysocioeconomic disadvantagesubstance misusesubstance usesubstance use preventiontraittrauma exposure
项目摘要
Project Summary
Rapid escalations in substance use during adolescence confer risk for the development of substance and
alcohol use disorders across the lifespan. Thus, identifying malleable risk factors and prevention targets that
emerge before substance use onset is an important public health goal. Research demonstrates that delay
discounting (DD), the tendency to perceive diminishing value in a reward as a function of the length of delay in
its receipt, is an important and modifiable risk factor for substance misuse. However, the early developmental
precursors of DD, including environmental adversity and genetic risk factors that are thought to be associated
with increases in DD across adolescence are not well understood. The extant literature examining these
vulnerabilities is limited by its reliance on poorly characterized markers of environmental adversity, lack of
consideration of developmental effects, and the genetic contributions to the development of DD. The current
application proposes to address these limitations utilizing data from the Adolescent Brian Cognitive
Development (ABCD) Study, a national sample of youth (n = 11,875) with planned longitudinal assessments
from age 9 to 17, spanning critical developmental periods for changes in DD and substance use. The
proposed project will leverage rich and varied indicators of adverse childhood events and community
environments (using the “Pair of ACEs” framework) and genetic data to create polygenic risk scores for DD
(informed by findings from the largest available genome-wide association study of DD performed by project
consultants). The project timeline will take advantage of both currently available and planned releases of data
to test study aims and accelerate dissemination of findings from this landmark study. Specific aims of the
study include: (Aim 1) to examine the structure of ACEs and its relation to early levels of DD; (Aim 2) to
characterize the impact of ACEs on measured trajectories of DD over time; and (Aim 3) to investigate the
joint associations between genetic and ACEs risk factors on changes in DD across adolescence. We also
propose to explore whether developmental trajectories of DD mediate the relation between genetic and ACEs
factors and subsequent changes in substance use frequency and severity. The research team brings together
expertise in child development, delay discounting, genetics, and environmental indicators of risk, allowing for
the most comprehensive study of the independent and joint contextual and genetic contributions to DD
development. Findings from this project will provide mechanistic insights into the development of DD, in
addition to specific and actionable advancements at the environmental level that may inform targeting of
prevention approaches for reducing substance use among at-risk youth.
项目摘要
青春期吸毒的迅速升级会带来吸毒的风险,
酒精使用障碍。因此,确定可塑性风险因素和预防目标,
在药物使用开始之前出现是一个重要的公共卫生目标。研究表明,延迟
折扣(DD),认为奖励价值随着延迟时间的长短而递减的趋势。
它的接收是药物滥用的一个重要和可改变的风险因素。然而,早期发展
DD的前体,包括环境逆境和被认为与DD相关的遗传风险因素
与青少年期DD增加的关系尚不清楚。现存的文献研究这些
脆弱性是有限的,因为它依赖于特征不佳的环境逆境标志,缺乏
考虑发育的影响,以及遗传因素对DD的发展。当前
应用程序建议利用青少年Brian Cognitive的数据来解决这些限制
发展(ABCD)研究,全国青年样本(n = 11 875),计划进行纵向评估
从9岁到17岁,跨越DD和物质使用变化的关键发育期。的
拟议的项目将利用丰富多样的儿童不良事件和社区指标
环境(使用“ACE对”框架)和遗传数据,以创建DD的多基因风险评分
(由项目进行的最大的DD全基因组关联研究的结果提供信息
顾问)。项目时间轴将利用现有和计划发布的数据
测试研究目标,并加速传播这项具有里程碑意义的研究结果。的具体目标
研究包括:(目的1)检查ACE的结构及其与DD早期水平的关系;(目的2)
描述ACE随时间对DD测量轨迹的影响;以及(目标3)调查
遗传和ACE风险因素对青少年DD变化的联合关联。我们也
本研究旨在探讨DD的发育轨迹是否介导了遗传和ACE之间的关系
物质使用频率和严重程度的因素和随后的变化。研究团队汇集了
在儿童发展,延迟折扣,遗传学和风险的环境指标的专业知识,允许
对DD的独立和联合背景和遗传贡献的最全面的研究
发展该项目的研究结果将为DD的发展提供机械的见解,
除了在环境层面取得具体和可采取行动的进展外,
减少高危青年药物使用的预防方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JULIA W FELTON其他文献
JULIA W FELTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JULIA W FELTON', 18)}}的其他基金
An Examination of the Joint Contributions of Socioeconomic Disadvantage, Genetics, and COVID-19 on the Development of Delay Discounting and Substance Use Across Adolescence
社会经济劣势、遗传学和 COVID-19 对青春期延迟贴现和药物使用发展的共同贡献的检验
- 批准号:
10689142 - 财政年份:2022
- 资助金额:
$ 43.46万 - 项目类别:
Improving Decision Making to Prevent Substance Misuse among Adolescents from Traditionally Underserved Communities
改善决策,防止传统服务不足社区的青少年滥用药物
- 批准号:
10708017 - 财政年份:2022
- 资助金额:
$ 43.46万 - 项目类别:
Improving Decision Making to Prevent Substance Misuse among Adolescents from Traditionally Underserved Communities
改善决策,防止传统服务不足社区的青少年滥用药物
- 批准号:
10508598 - 财政年份:2022
- 资助金额:
$ 43.46万 - 项目类别:
Improving Delay Discounting to Decrease Harsh Parenting among Parents Receiving Substance Use Treatment in a Low Resource Community
改善延迟折扣以减少在资源匮乏社区接受药物滥用治疗的父母的严厉养育行为
- 批准号:
10308820 - 财政年份:2021
- 资助金额:
$ 43.46万 - 项目类别:
Reducing Maternal Delay Discounting as a Target Mechanism to Decrease Harsh Parenting and Improve Child Mental Health Outcomes in a Traditionally Underserved Community
减少产妇延误折扣作为目标机制,以减少传统上服务不足的社区中的严厉养育行为并改善儿童心理健康结果
- 批准号:
10284541 - 财政年份:2021
- 资助金额:
$ 43.46万 - 项目类别:
Improving Delay Discounting to Decrease Harsh Parenting among Parents Receiving Substance Use Treatment in a Low Resource Community
改善延迟折扣以减少在资源匮乏社区接受药物滥用治疗的父母的严厉养育行为
- 批准号:
10450097 - 财政年份:2021
- 资助金额:
$ 43.46万 - 项目类别:
Improving Delay Discounting to Decrease Harsh Parenting among Parents Receiving Substance Use Treatment in a Low Resource Community
改善延迟折扣以减少在资源匮乏社区接受药物滥用治疗的父母的严厉养育行为
- 批准号:
10630341 - 财政年份:2021
- 资助金额:
$ 43.46万 - 项目类别:
Reducing Maternal Delay Discounting as a Target Mechanism to Decrease Harsh Parenting and Improve Child Mental Health Outcomes in a Traditionally Underserved Community
减少产妇延误折扣作为目标机制,以减少传统上服务不足的社区中的严厉养育行为并改善儿童心理健康结果
- 批准号:
10671617 - 财政年份:2021
- 资助金额:
$ 43.46万 - 项目类别:
Reducing Maternal Delay Discounting as a Target Mechanism to Decrease Harsh Parenting and Improve Child Mental Health Outcomes in a Traditionally Underserved Community
减少产妇延误折扣作为目标机制,以减少传统上服务不足的社区中的严厉养育行为并改善儿童心理健康结果
- 批准号:
10460563 - 财政年份:2021
- 资助金额:
$ 43.46万 - 项目类别:
Development and testing of a behavioral activation mobile therapy for elevated depressive symptoms
针对抑郁症状加重的行为激活移动疗法的开发和测试
- 批准号:
8979241 - 财政年份:2015
- 资助金额:
$ 43.46万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 43.46万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 43.46万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 43.46万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 43.46万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 43.46万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 43.46万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 43.46万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 43.46万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 43.46万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 43.46万 - 项目类别:
Research Grant